Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
4.085
+0.095 (2.38%)
At close: May 20, 2026, 4:00 PM EDT
4.150
+0.065 (1.59%)
After-hours: May 20, 2026, 4:44 PM EDT
Zura Bio Employees
Zura Bio had 40 employees as of December 31, 2025. The number of employees increased by 10 or 33.33% compared to the previous year.
Employees
40
Change (1Y)
10
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,653,350
Market Cap
388.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 40 | 10 | 33.33% | 40 | 0 |
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Replimune Group | 479 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| Verastem | 102 |
| Century Therapeutics | 78 |
| Fulcrum Therapeutics | 55 |
| Monopar Therapeutics | 22 |
ZURA News
- 6 days ago - Zura Bio reports employee inducement grants - TheFly
- 6 days ago - Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Zura Bio names Muzammil Mustufa chief business officer - TheFly
- 7 days ago - Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer - Business Wire
- 13 days ago - Zura Bio reports Q1 EPS (22c) vs (19c) last year - TheFly
- 13 days ago - Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
- 13 days ago - Zura Bio Quarterly report: Q1 2026 - Filings
- 13 days ago - Zura Bio Earnings release: Q1 2026 - Filings